CHICAGO (GenomeWeb) – Roche has agreed to support software vendor Syapse in the development of new analytics technologies with the goal of broadening access to precision medicine for cancer treatment.

The companies announced a multiyear collaboration today during the annual J.P. Morgan Healthcare Conference in San Francisco. Financial terms were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.